Celldex Therapeutics, Inc (CLDX)

Celldex Therapeutics (CLDX) is featured in a biotech stock watchlist for Q1 [----] readouts, indicating upcoming clinical trial developments that could impact its stock.

About Celldex Therapeutics, Inc

Celldex Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for cancer and other diseases.
Celldex Therapeutics, Inc uses the ticker $CLDX for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Celldex Therapeutics, Inc (CLDX) social dominance is up 146% from the previous week.
Celldex Therapeutics, Inc (CLDX) creators is up 40% from the previous week.
Celldex Therapeutics, Inc (CLDX) engagements is up 209.76% from the previous month.
Celldex Therapeutics, Inc (CLDX) mentions is up 52.33% from the previous week.
Celldex Therapeutics, Inc (CLDX) posts created is up 36.36% from the previous week.

Price: $23

Price 24-Hour Time-Series Raw Data
The stock's price action is bullish, reaching a 52-week high due to positive trial data and analyst upgrades, as evidenced by the 16.78% gain over the past [--] days. However, concerns about recent net losses and price volatility are tempering this upward trend, reflected in the 24-hour gain of -1.24%.

24-Hour: -2.79% 7-Day: -7.3% 30-Day: -10.33%

1-Year High: $29.80 on 2025-12-08
1-Year Low: $15.10 on 2025-04-08

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Celldex Therapeutics, Inc (CLDX) is currently AltRank #1,172 based on combined combined social and market metrics Daily Average: [-----]
[--] Week: [-----] [----]
[--] Month: [-----] +67
[--] Months: [-----] +868
[--] Year: [-----] +335
1-Year High: [-----] on 2026-02-11
1-Year Low: [---] on 2025-12-21

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-04-11
1-Year Low: [--] on 2025-12-26

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [------] +104%
[--] Month: [-------] +210%
[--] Months: [-------] -32%
[--] Year: [---------] -11%
1-Year High: [-------] on 2025-08-20
1-Year Low: [--] on 2025-04-13

Engagements by network (24h): X: [-----] Reddit: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +52%
[--] Month: [---] +29%
[--] Months: [-----] -28%
[--] Year: [-----] +25%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-04-13

Mentions by network (24h): X: [--] Reddit: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Celldex Therapeutics, Inc (CLDX) in the last [--] hours which is down 11% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] +40%
[--] Month: [--] +4.90%
[--] Months: [---] -54%
[--] Year: [-----] +62%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-04-13

The most influential creators that mention Celldex Therapeutics, Inc in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@BiopharmIQ	[--]	[------]	[--]	[-----]
@BuyTheUgly	[--]	[--]	[--]	[---]
@mariostario2019	[--]	[--]	[--]	[--]
@hotterc45506	[--]	[--]	[--]	[--]
@RahulGandi86155	[--]	[--]	[--]	[--]
@hg19290	[--]	[--]	[--]	[--]
@seedytx19	[--]	[-----]	[--]	[--]
@SMALLCAPSAXIS	[--]	[---]	[--]	[--]
@stocket_rocket	[--]	[--]	[--]	[--]
@it2mr0	[--]	[-----]	[--]	[--]

Sentiment: 75%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 75%
Daily Average: 78%
[--] Week: 100% no change
[--] Month: 68% -24%
[--] Months: 68% +7%
[--] Year: 68% +8%
1-Year High: 100% on 2025-02-26
1-Year Low: 13% on 2025-11-29

Most Supportive Themes:

Positive Trial Data: (40%) Recent positive trial data has been a significant driver for Celldex Therapeutics, boosting investor confidence and contributing to the stock's upward trend.
Analyst Upgrades: (30%) Upgrades from financial analysts have further bolstered the positive sentiment surrounding Celldex Therapeutics, influencing its current market performance.

Most Critical Themes:

Net Losses: (20%) Despite positive developments, Celldex Therapeutics has reported recent net losses, which are a point of concern for investors and may temper the stock's rally.
Price Volatility: (10%) The stock has experienced notable price volatility, a factor that could introduce risk for investors and influence short-term trading strategies.

Social Dominance: 0.00618%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00618%
Daily Average: 0.00651%
[--] Week: 0.00615% +0.00365%
[--] Month: 0.008% +0.0043%
[--] Months: 0.008% -0.0065%
[--] Year: 0.008% +0.0002999999999999999%
1-Year High: 0.034% on 2025-06-29
1-Year Low: 0.001% on 2025-12-25

Market Dominance: 0.00173%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00173%
Daily Average: 0%
1-Year High: 0.045% on 2025-03-31
1-Year Low: 0.00166% on 2025-04-09

Market Cap: $1,528,337,833

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $1,528,337,833
Daily Average: $1,532,981,140
[--] Week: $1,528,337,833 -6.70%
[--] Month: $1,528,337,833 -10%
[--] Months: $1,528,337,833 +10%
[--] Year: $1,528,337,833 +1.50%
1-Year High: $1,980,194,236 on 2025-12-08
1-Year Low: $1,004,387,060 on 2025-04-08

Top Celldex Therapeutics, Inc Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $BIVI Phase [--] $MDNAF Phase 2b $DBVT Phase [--] $GOSS Phase [--] $MLTX Phase [--] $BFRI Phase [--] $BCDA Phase [--] $KPTI Phase [--] $IOVA Phase [--] $XENE Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $ALZN Phase [--] $HELP Phase [--] $PVLA Phase [--] $INSM"
X Link @BiopharmIQ 2026-02-15T19:38Z 28.9K followers, 11.7K engagements

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $MDNAF Phase 2b $GOSS Phase [--] $BFRI Phase [--] $MLTX Phase [--] $BFRI Phase [--] $BCDA Phase [--] $KPTI Phase [--] $IOVA Phase [--] $XENE Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $ZBIO Phase [--] $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $NKTR Phase 2b $ALZN Phase [--] $HELP Phase [--] $PVLA"
X Link @BiopharmIQ 2026-02-08T18:59Z 28.9K followers, 21.6K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing